siRNA Therapeutics against Respiratory Viral Infections—What Have We Learned for Potential COVID‐19 Therapies?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
siRNA Therapeutics against Respiratory Viral Infections—What Have We Learned for Potential COVID‐19 Therapies? ; year:2021
Advanced healthcare materials ; (2021)
- Creator
- DOI
-
10.1002/adhm.202001650
- URN
-
urn:nbn:de:101:1-2021020308204420331114
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mehta, Aditi
- Michler, Thomas
- Merkel, Olivia
Other Objects (12)
Engineering siRNA therapeutics: challenges and strategies
Human antibody therapeutics for viral disease
Antitumoral polymeric siRNA nanoformulation and pretubulysin-based combination therapies
Quantum dot therapeutics: a new class of radical therapies
Viral and non-viral systems to deliver gene therapeutics to clinical targets
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Non-viral siRNA delivery into the mouse retina in vivo
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer
Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics
Toxicological evaluation of poly(ethyleneimine)-based non-viral vector systems for pulmonary siRNA application
Transplantation therapeutics
Arithmetical therapeutics
Engineering siRNA therapeutics: challenges and strategies
Human antibody therapeutics for viral disease
Antitumoral polymeric siRNA nanoformulation and pretubulysin-based combination therapies
Quantum dot therapeutics: a new class of radical therapies
Viral and non-viral systems to deliver gene therapeutics to clinical targets
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Non-viral siRNA delivery into the mouse retina in vivo
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer
Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics
Toxicological evaluation of poly(ethyleneimine)-based non-viral vector systems for pulmonary siRNA application
Transplantation therapeutics
Arithmetical therapeutics
Engineering siRNA therapeutics: challenges and strategies
Human antibody therapeutics for viral disease
Antitumoral polymeric siRNA nanoformulation and pretubulysin-based combination therapies
Quantum dot therapeutics: a new class of radical therapies
Viral and non-viral systems to deliver gene therapeutics to clinical targets
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Non-viral siRNA delivery into the mouse retina in vivo
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer
Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics
Toxicological evaluation of poly(ethyleneimine)-based non-viral vector systems for pulmonary siRNA application
Transplantation therapeutics